isatin and Breast Cancer
isatin has been researched along with Breast Cancer in 13 studies
Research
Studies (13)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 7 (53.85) | 2.80 |
Authors
Authors | Studies |
---|---|
Ali, F; Chauhan, G; Dubey, P; Khasimbi, S; Pathak, DP | 1 |
Arora, S; Bedi, PMS; Kaur, H; Singh, A | 1 |
Liu, J; Xu, Z; Zhang, X; Zhao, S; Zhou, W | 1 |
Huang, R; Shen, K; Wang, R; Wang, Z; Yuan, Y | 1 |
Diao, QP; Guo, H | 1 |
Awolade, P; Cele, N; Ebenezer, O; Gu, L; Gummidi, L; Kaur, M; Kerru, N; Palma, G; Singh, P | 1 |
Abdalla, AN; Al-Salem, HS; Albalawi, FS; Alkahtani, HM; Alqathama, A; Arifuzzaman, M; Issa, IS; Rahman, AFMM | 1 |
Al-Dhfyan, A; Alanazi, FK; Radwan, AA | 1 |
Chen, Y; Hou, L; Jiang, Y; Ma, Z; Song, J | 1 |
Hu, C; Lee, H; Solomon, VR | 1 |
Ahmed, EM; Khalil, NA; Taher, AT | 1 |
Indira Chandran, V; Locke, JM; Matesic, L; Ranson, M; Skropeta, D; Vine, KL | 1 |
Bremner, JB; Locke, JM; Matesic, L; Pyne, SG; Ranson, M; Skropeta, D; Vine, KL | 1 |
Reviews
2 review(s) available for isatin and Breast Cancer
Article | Year |
---|---|
In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isatin; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure | 2022 |
The anti-breast cancer potential of indole/isatin hybrids.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Indoles; Isatin; Molecular Structure; Structure-Activity Relationship | 2023 |
Other Studies
11 other study(ies) available for isatin and Breast Cancer
Article | Year |
---|---|
Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Line, Tumor; Estrogen Receptor alpha; Female; Fibroblasts; Humans; Isatin; MCF-7 Cells; Mice; Quinolines; Structure-Activity Relationship | 2022 |
Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
Topics: Antineoplastic Agents; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isatin; Molecular Structure; Structure-Activity Relationship | 2023 |
The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Isatin; Molecular Structure; Structure-Activity Relationship | 2020 |
Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Isatin; MCF-7 Cells; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Structure-Activity Relationship; Triazoles | 2021 |
A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 2; Cytotoxins; Female; Humans; Hydrazones; Isatin; MCF-7 Cells; Molecular Docking Simulation; Neoplasm Proteins; Ovarian Neoplasms; Protein Kinase Inhibitors | 2020 |
Synthesis, and docking studies of some fused-quinazolines and quinazolines carrying biological active isatin moiety as cell-cycle inhibitors of breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Female; Humans; Inhibitory Concentration 50; Isatin; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Quinazolines; Structure-Activity Relationship | 2013 |
The endogenous oxindole isatin induces apoptosis of MCF‑7 breast cancer cells through a mitochondrial pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Isatin; MCF-7 Cells; Membrane Potential, Mitochondrial; Proto-Oncogene Proteins c-bcl-2 | 2014 |
Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity.
Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Isatin; Thiazoles | 2009 |
Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Topics: Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; Female; Humans; Indicators and Reagents; Isatin; MCF-7 Cells; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thiazoles | 2011 |
Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Isatin; Molecular Targeted Therapy; Prodrugs; Receptors, Transferrin | 2012 |
N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents.
Topics: Alkylation; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Inhibitory Concentration 50; Isatin; Leukemia; Lymphoma; Male; Structure-Activity Relationship | 2008 |